Answer
Pedmarqsi (sodium thiosulfate) is preferably avoided during breastfeeding because milk excretion is unknown and infant risk cannot be excluded; it is only intended for use with cisplatin chemotherapy, during which breastfeeding is contraindicated.
Sources for this answer
- Pedmarqsi 80 mg/mL solution for infusionNorgine Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked